ESC Premium Access

The female gender as a risk factor of contrast-induced acute kidney injury in patients with chronic coronary syndromes

Presentation

About the speaker

Associate Professor Olga Mironova

I.M. Sechenov First Moscow State Medical University, Moscow (Russian Federation)
0 follower

187 more presentations in this session

The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure

Speaker: Professor J. McMurray (Glasgow, GB)

Thumbnail

CHA2DS2-VASc score as independent outcome predictor in patients with acute ischemic stroke with and without atrial fibrillation

Speaker: Doctor C. Su (Taichung, TW)

Thumbnail

Type and severity of migraine determines long-term risk of atrial fibrillation in women: a nationwide population-based study

Speaker: Doctor T. Rhee (Seoul, KR)

Thumbnail

Association between renal function and clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry

Speaker: Professor W. Shimizu (Tokyo, JP)

Thumbnail

The impact of maternal hypothyroidism on the prevalence of preeclampsia in a contemporary nationwide cohort.

Speaker: Doctor S. Alampoondi Venkataramanan (Worcester, US)

Thumbnail

Access the full session

Cardiovascular Disease in Special Populations ePosters

Speakers: Associate Professor O. Mironova, Professor J. McMurray, Doctor C. Su, Doctor T. Rhee, Professor W. Shimizu...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

The role of modifiable risk factors for the maintenance of sinus rhythm in the atrial fibrillation patient.

27 August 2021

ESC Premium Access

An asymptomatic patient with positive treadmill test during screening for life insurance and significant proximal LAD disease in coronary CT angiography: what do the guidelines say?

27 August 2021

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

This platform is supported by

logo Novo Nordisk